Intermountain Ventures is investing in a startup that uses generative AI to predict biological outcomes.
The venture capital arm of the Salt Lake City-based health system participated in a series A financing round June 3 for Matterworks. The company plans to employ the funding to advance its machine learning and scientific operations.
“Matterworks is leveraging AI to unlock a new data layer for biology by making mass spectrometry accessible to all biologists,” said Craig Asher, managing director of participating venture capital firm OMX Ventures, in a news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
